Inventor
HARTMAN GEORGE D
US172 patents
⚠️ This page may combine multiple inventors who share the name “HARTMAN GEORGE D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
35 patentsUS6306874B1Oct 23, 2001
Tyrosine kinase inhibitors
MERCK & CO INC214 citations99
US5856326AJan 5, 1999
Inhibitors of farnesyl-protein transferase
MERCK & CO INC280 citations99
US6875767B2Apr 5, 2005
(5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors
MERCK & CO INC87 citations98
US6794393B1Sep 21, 2004
Tyrosine kinase inhibitors
MERCK & CO INC75 citations98
US6586423B2Jul 1, 2003
Tyrosine kinase inhibitors
MERCK & CO INC151 citations98
US6420382B2Jul 16, 2002
Tyrosine kinase inhibitors
MERCK & CO INC120 citations98
US6313138B1Nov 6, 2001
Tyrosine kinase inhibitors
MERCK & CO INC130 citations98
US6066738AMay 23, 2000
Inhibitors of farnesyl-protein transferase
MERCK & CO INC94 citations98
US6927293B2Aug 9, 2005
Tyrosine kinase inhibitors
MERCK & CO INC69 citations97
US6586424B2Jul 1, 2003
Tyrosine kinase inhibitors
MERCK & CO INC95 citations97
US6048861AApr 11, 2000
Integrin receptor antagonists
MERCK & CO INC100 citations97
US5854245ADec 29, 1998
Fibrinogen receptor antagonists
MERCK & CO INC103 citations97
US6040311AMar 21, 2000
Integrin receptor antagonists
MERCK & CO INC64 citations96
US5968965AOct 19, 1999
Inhibitors of farnesyl-protein transferase
MERCK & CO INC85 citations96
US5814643ASep 29, 1998
Sulfonamide fibrinogen receptor antagonists
MERCK & CO INC48 citations96
US5741796AApr 21, 1998
Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated bone resorption
MERCK & CO INC82 citations96
US5719144AFeb 17, 1998
Fibrinogen receptor antagonists
MERCK & CO INC77 citations96
US5292756AMar 8, 1994
Novel sulfonamide fibrinogen receptor antagonists
MERCK & CO INC56 citations96
US5227490AJul 13, 1993
Fibrinogen receptor antagonists
MERCK & CO INC73 citations96
US5116870AMay 26, 1992
HMG-CoA reductase inhibitors
MERCK & CO INC62 citations96
US4940727AJul 10, 1990
Novel HMG-CoA reductase inhibitors
MERCK & CO INC52 citations96
US4751231AJun 14, 1988
Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
MERCK & CO INC56 citations96
US6958340B2Oct 25, 2005
Tyrosine kinase inhibitors
MERCK & CO INC73 citations95
US5281585AJan 25, 1994
Fibrinogen receptor antagonists for inhibiting aggregation of blood platelets
MERCK & CO INC107 citations95
US4735956AApr 5, 1988
Certain 1,4-dihydro-2,6-di-lower hydrocarbyl-4-heterocyclic-3,5-pyridine dicarboxylates which are useful as calcium channel blockers
MERCK & CO INC53 citations95
US5559127ASep 24, 1996
Fibrinogen receptor antagonists
MERCK & CO INC41 citations94
US5272158ADec 21, 1993
Fibrinogen receptor antagonists
MERCK & CO INC68 citations94
US6297249B1Oct 2, 2001
Integrin receptor antagonists
MERCK & CO INC18 citations93
US6090948AJul 18, 2000
Inhibitors of farnesyl-protein transferase
MERCK & CO INC47 citations93
US5952341ASep 14, 1999
Integrin antagonists
MERCK & CO INC49 citations93
US5925655AJul 20, 1999
αv β3 antagonists
MERCK & CO INC28 citations93
US5130306AJul 14, 1992
5-Oxygenated HMG-COA reductase inhibitors
MERCK & CO INC49 citations93
US5098931AMar 24, 1992
7-substituted HMG-CoA reductase inhibitors
MERCK & CO INC49 citations93
US4963538AOct 16, 1990
5-oxygenated HMG-CoA reductase inhibitors
MERCK & CO INC46 citations93
US4897402AJan 30, 1990
5-oxa, 5-thia, 5-aza HmG-CoA reductase inhibitors
MERCK & CO INC54 citations93
NOVIRA THERAPEUTICS INC
14 patentsUS9181288B2Nov 10, 2015
Azepane derivatives and methods of treating hepatitis B infections
NOVIRA THERAPEUTICS INC103 citations98
US9066932B2Jun 30, 2015
Hepatitis B antiviral agents
NOVIRA THERAPEUTICS INC39 citations97
US9061008B2Jun 23, 2015
Hepatitis B antiviral agents
NOVIRA THERAPEUTICS INC39 citations97
US9505722B2Nov 29, 2016
Azepane derivatives and methods of treating hepatitis B infections
NOVIRA THERAPEUTICS INC24 citations94
US9400280B2Jul 26, 2016
Piperidine derivatives and methods of treating hepatitis B infections
NOVIRA THERAPEUTICS INC24 citations94
US9339510B2May 17, 2016
Azepane derivatives and methods of treating hepatitis B infections
NOVIRA THERAPEUTICS INC25 citations94
US9169212B2Oct 27, 2015
Azepane derivatives and methods of treating hepatitis B infections
NOVIRA THERAPEUTICS INC28 citations94
US8993771B2Mar 31, 2015
Hepatitis B antiviral agents
NOVIRA THERAPEUTICS INC36 citations94
US9579313B2Feb 28, 2017
Hepatitis B antiviral agents
NOVIRA THERAPEUTICS INC19 citations93
US9205079B2Dec 8, 2015
Hepatitis B antiviral agents
NOVIRA THERAPEUTICS INC25 citations93
US9676747B2Jun 13, 2017
Hepatitis B antiviral agents
NOVIRA THERAPEUTICS INC20 citations92
US9550779B2Jan 24, 2017
Derivatives and methods of treating hepatitis B infections
NOVIRA THERAPEUTICS INC10 citations92
US9527845B2Dec 27, 2016
Derivatives and methods of treating hepatitis B infections
NOVIRA THERAPEUTICS INC11 citations92
US9518057B2Dec 13, 2016
Derivatives and methods of treating hepatitis B infections
NOVIRA THERAPEUTICS INC10 citations92
HARTMAN GEORGE D
1 patentShowing the top 50 of 172 patents by PatentIndex Score.